Pharm Co. Breckenridge Sues Rivals Over Generic Laxative

Law360, New York (November 2, 2011, 10:01 PM EDT) -- Breckenridge Pharmaceutical Inc. on Wednesday accused rival drugmakers UCB Inc. and Kremers Urban Pharmaceuticals Inc. of marketing prescription versions of Breckenridge's generic laxative product, despite a former agreement to stop distributing the drug.

In its complaint filed in New York federal court, Breckenridge alleges that even though UCB had obtained the U.S. Food and Drug Administration’s approval to market prescription laxative product Glycolax in 2004, it had entered into a superceding agreement with the FDA in June 2007 to stop distributing the drug from from December...
To view the full article, register now.




Case Information

Case Title

Breckenridge Pharmaceutical, Inc. v. UCB, Inc. et al

Case Number



New York Southern

Nature of Suit

Other Statutory Actions


Victor Marrero

Date Filed

November 1, 2011

Law Firms


Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.